ncr-fountain-ellison-alt

 REVEALED: 

The Secret Quest Of the World's Top Billionaires

It's not about the next generation of computers, driverless cars, virtual reality, smartphones, space exploration, or robots.

They're spending billions on a tech that can satisfy the core desire of every man, woman, and child on earth.

And it could make you wildly wealthy in 2019...

double-down-arrow-white

Dear Reader,

Silicon Valley's wealthiest folks have it all...

Mansions around the globe, massive yachts, a fleet of private jets, garages full of the finest cars in the world, a lasting legacy, and the perfect family...

They've truly conquered the world. But there's still one thing they all want...

Heck, it's something that's the core desire of every man, woman, and child on the planet.

"An ancient yearning," as The New Yorker calls it.

These top billionaires can't afford it — yet.

But they're frantically spending billions on their "quest" to get it.

For example...

  • Google cofounder Larry Page has invested $750 million in it.
  • Oracle cofounder Larry Ellison has spent $430 million on the quest so far.
  • Facebook founder Mark Zuckerberg is pledging $3 billion to the quest.

And this billionaire spending frenzy has already set things in motion...

People are making money hand over fist.

Several of the companies that are helping them with this "quest" have taken off and handed regular investors BIG paydays.

For example...

  • A firm named Cellectis jumped by 1,067% in less than a single year.
  • A New York-based company named Regeneron Pharmaceuticals soared by 2,646%.
  • And a firm in Georgia called the MiMedx Group skyrocketed by 3,740%.

That's a combined 7,453% in gains.

And it would turn every $10,000 you invest into a whopping $755,300.

Imagine how that kind of windfall could affect your life...

That could be enough to fund your whole retirement, put your kids or grandkids through school, and still have plenty left over for a giant inheritance.

And yet, it's only the beginning of the wealth that this frenzy is throwing off to everyday investors...

You see, this quest is entering a whole new phase, which will be unlike anything we've seen in the past.

The stakes simply couldn't be higher.

And it'll create a wealth tsunami that's BIGGER than anything we've ever seen.

But first, you may be wondering...

"Tech titans' latest project"
— The Washington Post

What's this "quest" that the world's wealthiest are spending billions of dollars on?

What's the thing that these billionaires want more than anything else in the world and at any cost?

It has nothing to do with the next generation of computers, driverless cars, virtual reality, smartphones, space exploration or robots.

It's has to do with something that everyone on the planet wants, too.

Something so precious that it can't be bought at any price...

And that thing is more time.

Yes, I'm talking about the possibility of living forever, or at the very least, prolonging your life for as long as possible.

I know that sounds crazy...

But that's exactly what the most iconic leaders in Silicon Valley are working on right now.

In fact, they're investing in new life-extension technologies and research at unprecedented levels. Like...

  • Google cofounder Larry Page. He invested $750 million in the founding of the California Life Company, or Calico, an ultra-secretive anti-aging research center.
  • Oracle cofounder Larry Ellison has donated more than $430 million to anti-aging research. As Ellison says: "Death never made any sense to me."
  • Peter Thiel, who turned a $500,000 early investment in Facebook into $500 million, donates $5 million a year to anti-aging research. And he's publicly proclaimed that he will live to 120.
  • Facebook's Mark Zuckerberg has pledged $3 billion over the next 10 years to "cure, prevent and manage all disease." He's also the founder of the Breakthrough Prize, which awards $33 million annually to scientists who discover new ways to extend human life.
  • Sergey Brin, another Google cofounder, has invested millions of dollars in a genetics company that's fighting to cure age-related diseases such as Parkinson's.

And Amazon CEO Jeff Bezos, the world's richest man, has invested millions of dollars in a tiny anti-aging firm!

It's one that could very well hold the key to halting and reversing all age-related diseases.

I'll tell you more about this small firm's breakthrough medical technology in just a moment...

Nobody wants to miss out on this historic investment opportunity.

But here's the bottom line...

Throughout history, people have searched for the fountain of youth.

Today, Silicon Valley's billionaires believe they can create it with technology and data.

Now, I'll admit that this all sounds pretty far-fetched...

But after months of exhaustive research, I can say with confidence that this could become the most profitable financial opportunity in the history of mankind.

Over the next few minutes, I'll prove this bold claim by taking you through some of the incredible breakthroughs happening right now in the anti-aging field that you've likely never heard of...

And I'll tell you how being an early investor in these technologies could have already made you wildly rich.

Plus, I'll reveal the details about the small firm that Bezos is backing, its world-changing breakthrough, and why it's about to become the epicenter of it all.

The anti-aging industry generates $250 billion globally.

By 2021, that number is expected to rise to $331 billion.

And by 2025, it's expected to explode to $1 trillion!

That's 5 Times Bigger Than The Entire Cancer Drug Industry!

double-down-arrow-white

And that's only the beginning...

Make no mistake about it: Understanding this trend — and most importantly, how to make an early investment in it — could not only help you extend your own life, but it could also make you unbelievably rich in the process.

After all, of all the things that money can buy, wouldn't more time be at the top of the list?

If you could realistically extend your life by 20 or even 30 years, wouldn't you want to do it — no matter the cost?

Don't you think the rest of humanity would feel the same way?

Now, at this point, you may be thinking: "I'm too old for this new technology to make a difference in my lifetime. So, why should I care?"

Well, according to some of the world's top scientists, you may be wrong about that...

"The first person to live to 1,000
might be 60 already."
— Dr. Aubrey de Grey, Cambridge University


Dr. Aubrey de Grey of Cambridge University has dedicated his life to making yours longer.

He's the founder of SENS Research Foundation (SRF), an age-related disease-fighting public charity, which has received massive donations from tech billionaires like Peter Thiel.

"Over 100,000 people die every day from age-related diseases," de Grey says. "But research ventures [such as SENS] promise to one day end this carnage."

In fact, the majority of older Americans will encounter some kind of chronic ailment as they age. Whether it's arthritis, diabetes, or heart disease, the longer you live, the more likely you are to get sick.

According to the National Council on Aging (NCOA), about 92% of older adults have at least one chronic disease, and 77% have at least two.

So, it's no wonder why these anti-aging scientists have Silicon Valley emptying its pockets...

There's a massive demand for a solution to the problem of aging!

And it looks like that solution could be right around the corner...

"The lifespan is going to continue to increase," says Eytan Abraham, head of cell therapy research at Lonza, a global life sciences company. "I think that's quite clear."

Author and famed futurist Ray Kurzweil confirmed recently that we are in the early stages of an anti-aging revolution. "By 2026," he says, "biotech upgrades will add more than one year of life expectancy to our lives each year"...

The Death of Death

And here's the best part: You don't need to be a billionaire to take advantage of what these geniuses are pioneering.

Since the early days of the anti-aging industry, there have been several pioneering biotech firms that made early investors incredibly wealthy.

I'm talking thousands of percent gains within a short period of time.

But they've also changed the world and saved people's lives.

I'm talking about people like Antonio Guadagnino.

Antonio is a certified public accountant (CPA) with a demanding tax practice in Astoria, Queens, New York.

And thanks to a company called Intuitive Surgical, he's alive.

On August 6, 2012, while working with a client at his desk, Antonio had a sudden severe pain in his left side that put him in the emergency room.

There, doctors discovered that he had a tumor on his left kidney the size of a lemon. Tests confirmed that it was cancerous.

Antonio was in a race against time. He saw three different urologists who all told him that they'd have to remove the entire kidney to save his life.

The thought of losing a kidney was too much for Antonio to bear. So, he continued to look for a better solution. He needed a miracle.

Finally, Antonio found himself at Mount Sinai Hospital in New York City where he met with an expert on minimally invasive robotic kidney surgery.

The way it works, a small 3D camera and dime-sized surgical instruments are placed inside the patient through tiny incisions. The camera gives the surgeon a magnified 360-degree view of what's being operated on.

Then through a console with hand and foot controls, the surgeon remotely moves robotic arms attached to surgical instruments.

Here's the advantage: Compared to traditional techniques, the small incisions created by robotic surgery drastically reduce patients' time in the hospital and their risk of infections.

On October 4, 2012, Antonio went into surgery. And thanks to this incredible technology, doctors were able to remove the tumor and save Antonio's entire kidney.

That's Antonio in the middle. Today, he's cancer-free.

Antonio is only one of the countless patients whose lives have been saved by this breakthrough technology.

But what may be even more astonishing is the amount of money that Intuitive Surgical has made for its shareholders over the past 16 years.

After going public in 2000, Intuitive Surgical stock traded for around $14, adjusted for stock splits.

Today, the stock is trading at $519:

That's an incredible 3,607% gain. And it's enough to turn a small $5,000 initial stake into $185,350.

This is one of the earliest examples of the anti-aging revolution in action: a company with a new lifesaving technology that has quickly made its shareholders extremely wealthy.

And it's not the only one...

1,678% Gain in Less Than One Year

double-down-arrow-white

Not long ago, 11-month-old Layla was dying from leukemia. All traditional treatments had failed, and her parents were feeling desperate.

"We didn't want to give up on our daughter," her mother, Lisa, said. "So we asked the doctors to try anything."

After much debate, doctors at Great Ormond Street Hospital in London decided to use an experimental form of therapy with genetically engineered immune cells from a donor.

Amazingly, within a month, these immune cells killed off every cancerous cell in Layla's bone marrow.

Doctors will keep a close on her to ensure that her cancer doesn't return. But for now, Layla is effectively cured.

The treatment, which is considered a world first, was made possible by a Paris-based life sciences company Cellectis.

Cellectis S.A. (Paris: ALCLS) is a biopharmaceutical company. It develops revolutionary treatments for cancer, such as gene editing.

In Layla's case, the basic idea was to remove immune cells from a healthy patient's body, genetically engineer them to attack cancerous cells, and place them into the sick patient.

This is only one application of breakthrough therapy. In the future, such gene-editing techniques could be used to eliminate a host of diseases. That includes many types of cancer and even HIV.

And success stories like Layla's are what have investors excited about the company's potential.

Starting in late 2014, Cellectis stock began to skyrocket. By May 2015, the price jumped from $2.30 to $40.90 a share — a 1,678% gain in less than a year:

That's enough to turn every $5,000 invested into $83,900 in profits practically overnight.

But the gains of Cellectis aren't much at all compared to the company that's essentially cured a deadly disease that currently affects up to 3.9 million Americans...

3,550% Gain Since 2001

30 years ago, a woman named Roxy contracted hepatitis C.

This deadly disease swells the liver and prevents it from doing its job: changing food into energy and also cleaning alcohol and poisons from the blood.

When Roxy started to exhibit symptoms a few years ago, she went to the doctor without much hope.

"I figured that me going to the doctor to be seen for the hep C was me meeting the person that was going to monitor my death," said Roxy.

You see, about 75% to 85% of people who become infected with the hepatitis C virus develop a chronic infection.

This means that the patient has the disease for life and that there's a high probability of developing serious liver problems, like cirrhosis and liver cancer.

But instead of being handed a death sentence, Roxy's doctors gave her a treatment option that was "too good to be true."

The breakthrough drug that Roxy was given, which was only released to the public starting in December of 2013, is called Sovaldi.

Sovaldi has a success rate from 75% to 90%.

Just 14 weeks after starting treatment, Roxy was declared virus-free after 30 years of suffering from the formerly incurable disease!

"I am cured," she said. "I have my life back."

Thanks to breakthroughs like Sovaldi, the company that develops the drug, Gilead Sciences, has taken shareholders on an incredible ride over the past 15 years.

Since 2001, the stock has jumped by more than 3,550%. That's enough to turn every $10,000 stake into $365,000:

This is one of the best early examples of the anti-aging revolution. It's a company that's developing lifesaving medications and rewarding investors tremendously within an extremely short period of time.

But there's one more company out there that may be doing even more to help extend the human life span while it's making its investors rich...

2,646% Gain Since 2009

Heart disease is responsible for around 1 in every 4 deaths in the U.S.

The fact that it kills more than 600,000 people per year makes it the leading cause of death for both men and women.

It's one of the deadliest age-related diseases in the world. So, finding a way to slow it down is big business.

That's why the Wall Street Journal calls the new cholesterol drug Praluent a "desperately needed option for several million high-risk heart patients who can't get their cholesterol to desirable levels."

The Food and Drug Administration (FDA)-approved drug is produced by a company called Regeneron Pharmaceuticals in partnership with Sanofi S.A.

Regeneron Pharmaceuticals produces several medications, which includes the anti-inflammatory Arcalyst and the chemotherapy drug Eylea.

In its 2013 annual shareholder letter, Regeneron announced that Eylea injections alone produced net sales of $1.4 billion for the company.

And amazingly, Regeneron's newest drug, Praluent, has been proven to help reduce cholesterol levels up to 72% more than competing medications.

This could be a game-changing drug for millions of older men and women who are at higher risk of developing heart disease.

As CBS News medical contributor Dr. David Agus says: "This is a fantastic tool. It is a very important drug."

The high cost and incredible success rates of the drugs that Regeneron produces is the main reason why the company's stock has skyrocketed over the past few years.

Since 2009, it's up by an incredible 2,646%:

If you'd gotten in early on this anti-aging company, you could have turned every $5,000 that you invested into an unbelievable $137,300 — within only a few years!

These four companies are some of the best examples of the first wave of the anti-aging boom.

If you'd have gotten in early on any one of them, you could have made an absolute fortune.

If you'd have gotten in on all of them, you could have turned a $5,000 investment in each into a staggering $408,700.

And that brings me to the point of this presentation...

I've identified a small company that's poised to dominate the new wave of the anti-aging industry.

It's the next company that could make smart, forward-thinking shareholders like you extremely wealthy.

And it's one that Jeff Bezos is pouring millions upon millions of dollars into...

Jeff Bezos

The New Breed

And the time to get in on it is now!

Aside from billionaires like Jeff Bezos throwing their money into the ring, there's another BIG reason why you need to invest in this industry...

And that's because we've reached a tipping point, and there's no time to wait.

In short, the world's population is undergoing the most rapid aging in its history.

According to the World Health Organization (WHO), by 2020, the number of people aged 60 years and older will outnumber children younger than 5 years old.

"The pace of population aging is much faster than in the past," says WHO.

And it's why British billionaire Jim Mellon says: "This... will lead to the life science sector gaining new prominence and... the biggest successes in this sector will ultimately dwarf the likes of Apple, Exxon and BHP..."

You heard that right...

Shares of Apple have returned 62,911% to investors since its initial public offering (IPO).

That would turn every $100 into $63,011...

And this opportunity could dwarf it!

"Obviously, the size of the return is huge," says Kevin Perrott, president of the Global Healthspan Policy Institute. "If you're able to bring anything like that to the market, you have something that's universally needed."

This means that you have a once-in-a-generation opportunity to reap a retirement fortune on what could be the biggest medical breakthrough of all time.

After all, who wouldn't pay money to extend their life by a decade or two or three?

In a moment, I'll give you the details on the single company that's poised to revolutionize the anti-aging field...

And I'll explain how you can profit from it.

History shows that a breakthrough of this size could produce a gain of up to 3,607%!

And if you act quickly, you could be one of the few fortunate investors to turn a small stake into hundreds of thousands of dollars — if not millions...

But first, it's important for you to know who I am and why I've never been more certain about anything else in my career...

My Name Is Alex Koyfman

double-down-arrow-white

I'm a senior investment analyst in Baltimore, Maryland, where I've run a multimillion-dollar investment research business for the last 10 years.

Over this time, I've developed a strong reputation for my scientific investing strategies, which have helped my subscribers make solid investments, grow their assets rapidly, and ensure they're protected no matter which way the market turns.

This has worked so well for my subscribers and me that I've been able to build a high-averaging portfolio that outperforms any hedge fund in operation today.

So, what's the secret sauce behind my strategy?

In theory, it's simple: I find little-known companies before the mainstream investment community piles into them — stuff that's flying under the radar of the big Wall Street players.

I get into these companies early while shares are cheap and undervalued, right as they're about to take off, and I watch my investments grow by leaps in bounds — sometimes overnight.

For example, within the last two years alone, my portfolio has locked in gains with the following positions:

  • 300% on Dajin Resources Corp.
  • 210% on Versus Technology
  • 160% on Vinergy Resources Ltd.
  • 105% on LiCo Energy Metals
  • 96% on MCW Energy Group Limited
  • 90% on Defiance Silver Corp.
  • 88% on Everton Resources
  • 67% on LRAD Corporation
  • 64% on BioMmune Technologies

To put that into perspective, if you'd invested a measly $500 into each of those companies for a total of $4,500, you would have turned it into $10,400 in less than 25 months.

If you'd invested $1,000 into each for a total of $9,000, you could have turned it into $20,800.

And I'm not just cherry-picking a few successful plays that I've recommended to my readers.

For example, take a look at my entire portfolio from 2017. These are all the positions I recommended to my readers:

As you can see, that's five closed positions with immense profits of 560%, 105%, 89%, 88%, and 57% gains.

That would have transformed $5,000 into $13,990 within four measly months. 
Here's my portfolio from 2016 with 10 total closed positions:

As you can see in the right-hand gain-loss column, of these 10 positions, one was a BIG loser — but only one. 
That's still a 90% win rate.


And these aren't small gains, either. We're looking at 300%, 210%, 90%... So, $1,000 into each of these companies for a total of $10,000 would have transformed into $17,550, which includes that single loss. That would have been the easiest money you've ever made.

Imagine placing a single, simple, expertly researched trade and going on about your business...

Then, just a few weeks or few months later, you see your money grow by 50%, 100%, 500%, and even 1,000% or more...

That's money you made in your sleep. It's money that could go toward your dream vacation, grow your retirement nest egg, help out your kids, and maybe even get you that boat or car you've always wanted.

In fact, let's go a little further back to 2015...
 Here you can see we had a 100% win rate with a total of nine plays:

Every year, readers who follow my investment strategy see almost 100% wins with double- and triple-digit gains.

And every day, I receive glowing testimonials like these:

"Just wanted to say 'YOU NAILED IT.'"

— L. McConkey

"Thank you for the sell. I made a quick $1,300."

— W. Gray

"Thanks for all of your great tips and extraordinary insights. I have done well listening to your advice!"

— S. Menere

Now, I'm not telling you all this to brag — far from it.

I'm telling you this because this is the track record that you should expect from somebody who spends all their time pinpointing today's best investment ideas before they go mainstream.

And the research that I've done on the tiny company that's set to dominate the anti-aging industry has got me more excited than any other opportunity I've invested in or recommended to my readers over the last four years.

And it's because it could solve the biggest problem on planet earth: the problem of aging!

How can that be possible?

Let me explain...

The Real Cause of Aging, And the Solution

You see, most people believe aging is unavoidable.

They think the human body is like a machine that naturally gets tired and breaks down from normal everyday use.

But that's just not true...

Scientists have only recently discovered the true cause of aging.

Here's how it works...

From the moment we're born, the cells in our body start to divide.

By doing this, they rejuvenate our muscles, blood vessels, and skin cells.

But as we age, older cells in our body stop dividing. They stop functioning. They can even stop new cells from growing.

These cells that have stopped working are called "zombie" cells.

These zombie cells build up in our body because our immune system can no longer get rid of them.

These cells are associated with a number of diseases related to aging.

These diseases include diabetes, Alzheimer's, heart disease, cancer, and more...

Consider this... Of the 150,000 people who die every day, 110,000 of them die from these age-related diseases.

That makes it the BIGGEST cause of death in the world!

There's virtually no bigger medical problem — period.

But what if there's a drug that could eliminate these zombie cells from our bodies?

Well, then it could prevent the onset of these ravaging age-related diseases.

Therefore, you can stay healthier for a lot longer...

Mayo Clinic Produces Breakthrough Study

double-down-arrow-white

This was the idea that doctors at the Mayo Clinic set out to test.

The Mayo Clinic is ranked as the No. 1 research hospital in the entire U.S. by U.S. News & World Report.

Doctors at the clinic created a drug "cocktail" that's specifically designed to target zombie cells.

They conducted a study using this cocktail on mice.

And the results were nothing short of stunning...

According to Dr. Darren Baker, a molecular biologist at the clinic: "We have found that the elimination of [zombie] cells from naturally aged mice extends their healthy life span."

The mice lived up to 36% longer.

Could you imagine extending your own life by as much as one-third or more?

And get this...

Not only did the animals' life span increase...

But during their extra years of life, they were spry, strong, and healthy.

They were not frail, decrepit, and sick — as is the case with almost half of people over the age of 85...

"An entirely new way to treat aging."
— Dr. Norman Sharpless, University of North Carolina
School of Medicine

Now, here's the thing...

There's one company that's licensed this breakthrough medical technology from the Mayo Clinic...

In fact, this company was cofounded by the Mayo Clinic's lead author of this groundbreaking study!

In other words, it's the first company to use this medical technology in human trials, which is an unprecedented step for the entire biotech industry.

This is HUGE and has the potential to deliver historic profits.

This entire team is, quite frankly, the most impressive group of people I've ever seen...

I'm talking flat-out geniuses at every level.

Almost every one of these folks has a Ph.D. from places like University of California, Berkeley; Tufts University; and the Oxford University.

And they're all world-class experts in their fields...

The CEO is a 23-year industry veteran and a true superstar in the business.

In fact, before taking the helm of this company, he was the President of another start-up that was acquired by Allergan for $2.1 billion.

Shareholders who went along for the ride could've banked gains of 233%!

In short, this small company has put together a biotechnology dream team.

Its sole mission is to eliminate these stagnating cells in our bodies that cause the painful, debilitating diseases associated with old age.

And it already has several promising drugs in the pipeline that are designed to do just that.

The first disease it's tackling is osteoarthritis.

It's the most common form of arthritis among adults in America. It affects 27 million people.

In fact, osteoarthritis drugs represent a $2.6 billion market opportunity in the U.S. alone.

But it's only the tip of the iceberg...

Because if this drug succeeds in reversing osteoarthritis, it could be the foundation for reversing pain elsewhere in the body.

It could give health and youth back to hundreds of millions of people.

And it could make you downright rich...

This Is a Monster Home Run in the Making

And the smart money knows it, too.

There's a reason why all these Silicon Valley billionaires are injecting their money into this field.

Billionaires that include Mark Zuckerberg, Oracle cofounder Larry Ellison, Google cofounder Larry Page...

And Jeff Bezos, who has personally selected this company to invest his millions into. And he doesn't just throw money at companies willy-nilly.

Jeff Bezos invested in a cancer drugmaker called Juno Therapeutics back in 2014.

The company got bought out by Celgene for a whopping $9 billion!

Had you bought shares of Juno back then, you could have cashed out with a gain of 263%!

I expect the gains that you could reel in from this new play could be 10 times bigger that.

After all, aging is the largest medical problem the world faces today.

This single position could have you traveling the world, relaxing on tropical beaches, and playing some of the best golf courses out there.

That's how promising this opportunity is.

Now, I don't want to mislead you. I don't have a crystal ball. And if anyone tries to come to you saying they have one, turn around and RUN. There's always risk in investing — period. That's why I do such intensive research in order to give my followers an edge.

And after putting countless painstaking hours of research into this company, I truly believe this is one of the lowest-risk, highest-upside profit plays I've ever come across in my investing career.

Today, I'd like to give you the same edge that my readers have. That's why I've put all the details of this investment into a special briefing, called...

"The Fountain of Youth: Banking 1,000% on the Billionaires' Quest to Stay Young"

ncr-fountain-youth_report-v2

This report tells you everything you need to know about this innovative company, the disruptive technology its created, and why its set to be the leader of this new frontier of anti-aging research.

By the time you finish reading it, you'll be armed with all the knowledge you'll need to make the investment of a lifetime. That includes a full profile on the company's core leadership, a comprehensive outline of the company's technology, and all the important details of the opportunity itself. That includes its ticker symbol, market capitalization, outstanding shares, and my recommended "Buy" prices.

And I'll give you a way to claim this report FOR FREE at the end of this presentation.

Again, there's no bigger problem in the medical world today than these age-related diseases. It's the cause of the vast majority of deaths in the world.

Silicon Valley billionaires have made it their personal missions to help people prolong their lives for as long as possible.

That means curing diseases that range from cancer to Alzheimer's and diabetes.

They're piling billions of dollars into achieving this goal.

And I believe this small company will become the darling of this market, thanks to its breakthrough medical technology.

Remember, I've already shown you how past breakthroughs in this sector have produced gains of 1,678%, 2,646%, 3,550%, and 3,607%.

And this company could dwarf them all!

But there's no time to hesitate. This company won't stay a dirty little secret for long. And these shares won't remain as undervalued as they are now.

Again, my report, "The Fountain of Youth: Banking 1,000% on the Billionaires' Quest to Stay Young," can be yours — absolutely free.

But I'm not quite finished yet...

There are several other big investment opportunities that could double, triple, and even quadruple your money over the next few months.

To help you capture those opportunities, I have two additional reports that I want to give you today — also free of charge...

New Report to Spark $7 Trillion Industry

ncr-road-zero_report

The second report is called: "The Road to Zero: 1,500% Gains on This $7 Trillion Tech Revolution."

Right now, automakers, tech firms, component suppliers, and ride-sharing companies are pouring billions of dollars into developing self-driving cars and trucks.

Why? Because a new study from Intel shows the payoff could be worth $7 trillion.

And as the first fully autonomous-drive vehicles hit the road over the next few years, an entire global "passenger economy" will be created.

This will set off a massive chain reaction of profits as the market grows exponentially.

Plus, they could save millions of lives — as much as 10 million lives per decade!

Over the next few years, the driverless car market, which is worth $126.8 billion today, is set to grow 55 times bigger.

And the companies that provide the actual technology for inside these vehicles are poised to go parabolic.

And I've found the one stock that stands to rule them all...

That's because it supplies the most essential piece of tech needed to get driverless cars on the road.

And demand is about to soar. Apple and Amazon are already using this company's systems right now.

In fact, this stock has already started to move up. And I'm confident that early investors will conservatively see double- and triple-digit gains within the next few months alone.

Everything you need to know about this company is in my second special report: "The Road to Zero: 1,500% Gains on This $7 Trillion Tech Revolution."

But that's not all! I also want to give you one more report, called: "The China Killer: A Pure Play in 21st Century American Manufacturing."

American industry is, in fact, making a comeback.

But it's not exactly what you would imagine...

Today's resurgence in manufacturing isn't driven by steam and muscle...

Instead, it's being driven by software and electronics.

And there's one single company at the helm that's helping to bring America back to a position of global manufacturing dominance.

It already has its hands in deals on almost every continent. This includes countries like Australia, Brazil, Canada, India, and Sweden.

The best part is, it's caught China with its pants down...

And shares of its stock are ripe for a huge run.

You'll find out everything about this company in your second FREE bonus report: "The China Killer: A Pure Play in 21st Century American Manufacturing."

Because you're a new member of New Century Report, I want you to have your "The Fountain of Youth: Banking 1,000% on the Billionaires' Quest to Stay Young" report and also your "The Road to Zero: 1,500% Gains on This $7 Trillion Tech Revolution" and "The China Killer: A Pure Play in 21st Century American Manufacturing" bonus reports for free.

ncr-fountain-reports-v4

New Century Report Is a Research Service That I Designed for You

double-down-arrow-white

Remember earlier in this presentation when I showed you my portfolio from 2017, 2016, and 2015 with all those double- and triple-digit gains?

Well, those recommendations were shared with my subscribers.

You see, I let them look over my shoulder and see my model portfolio, which gave them the chance to invest in my best stock picks.

And today, you can be one of those subscribers who get to look over my shoulder. And you can do it absolutely risk-free — more on that in a moment...

Through this service, you'll join me as I exploit a number of industries by looking at historic growth potential as the nation's social and economic balance shifts.

I'm talking about upward of $40 billion in consumer spending migrating into these traditionally quiet sectors.

For example, one sector that's seeing HUGE growth is the defense sector.

Just recently, I sent out this urgent alert to my existing subscribers:

Dear New Century Report Investor,

Just a short update today, and it's to say goodbye to one of our defense industry plays.

We're selling Direxion Dly Aerospace&Def BI 3X ShsETF (NYSE: DFEN) at or above $41.30 for a tidy 47.5% gain on a hold time of almost exactly three months.

Imagine if you were a subscriber...

You would have simply followed my instructions to get into this particular position at a particular share price.

And three months later, you would have gotten out with an almost 50% gain!

You see, I do all the research for you...

The moment you become a member of New Century Report, which you can do risk-free, by the way, you'll become part of my "inner circle." And you'll gain access to my research and all the investment opportunities that I uncover each and every month.

Here's what else you'll get as a member of New Century Report:

  • Access to my model portfolio. This portfolio includes every stock on my "buy now" list. Each of my recommendations comes with zero guesswork. You'll see a clear entry point where I explain when you should buy. You'll also receive clear exit notifications so you'll never have to guess when it's time to take your gains or cut your losses.
  • Weekly market updates. With these weekly updates, you'll never be left in the dark. Once a week, I'll reach out to you with an update on our current positions and on what's happening in the markets.
  • Trade alerts. When it's time to make a trade, I'll send you email alerts that tell you exactly what to do. And with today's technology, should you choose to invest, you could make that trade over your phone, on your desktop, or even with your tablet. It's that easy.
  • Monthly issues. This is actually my favorite part. Each month, I dive into a specific topic. Usually, this topic revolves around a new investment that I'm targeting. Basically, I'll take you down the rabbit hole and reveal industry-specific information that you'd never find from a Google search or from watching CNN.
  • Comprehensive research reports. Whenever my research points me to a new investment opportunity, I always compile a comprehensive research report for you that covers everything you'll need to know about the stock, the company, and the opportunity. Although the information is always comprehensive, I'll boil it down in a simple, no-fluff, and easy-to-understand way.
  • 24-7 access to your private members' area. In the private members' area, you'll see all current and past issues of New Century Report, all current and past reports, and more. You'll have access to all of it in your encrypted, privacy-secured members' area, which is easy to access anytime and from any device — anywhere.
  • Dedicated customer service team. Of course, you'll also get access to a dedicated customer service team run by real people. They're available by phone five days a week or through email 24-7, in case you ever have any questions about your membership. They'll walk you through whatever you need.

A membership to New Century Report translates to big gains for people who follow my research.

I'm proud of these successes.

But if I'm being completely honest, they pale in comparison to the opportunities that I see on the horizon — like the ones I've told you about in this presentation.

But you need to hurry. We are on the precipice of HUGE moves in these sectors. And the companies that I talked to you about in this presentation are set to surge.

Any ultra-rich investor would tell you the same thing: Making big gains in the market is all about timing.

And right here, right now is the perfect moment. But you'll have to take quick, decisive action.

You don't want to be the person who gets into an investment after it's already skyrocketed by 400%.

You want to be the person who's smart enough to get in when shares are undervalued and cheap and also ride that wave all the way to the top just to exit with insane gains.

That's what you'll be able to accomplish as a new member of New Century Report...

You Could Make 100 TIMES What It Costs to Join

With a perfect storm of investment opportunity unfolding right before our eyes, there's never been a better time to join New Century Report than right now.

And because I want you to get in on the ground floor of these immense double- and triple-digit gains, I don't want anything to hold you back.

You see, helping you achieve an immense amount of wealth is my mission. It brings me great joy to know that I can help others achieve their financial dreams.

That's why I've kept the cost to join New Century Report at the lowest possible level: only $79.

Honestly, it's a steal at that price.

After all, $79 for a year breaks down to a measly $6.50 a month. That's about as much as one supersized Big Mac meal.

To break it down even further, it's only $0.22 a day.

And really, what else would you spend $79 on this year that will actually grow your income and could make you rich?

By the way, those three special reports that I've promised you today each have a $99 value — worth $297 all together.

But again, I don't want anything to hold you back from this decision today.

So, to remove absolutely any barriers or doubts that could prevent you from joining, here's what I've decided to do...

I'm going to make this a no-brainer — a 100% risk-free decision.

Take the next 60 days to review everything in New Century Report. If I don't live up to your expectations, or if you simply don't think that the research or strategies are for you, simply call my team. You'll receive every penny of your $79 membership fee back.

And understand something: That process will be painless. There will be no questions, no delays, and no attempts to convince you to stay.

If you call or email our dedicated support team and ask for your money back for any reason within 60 days of your purchase, you'll get your $79 credited back to your account within three to seven business days.

It doesn't get any better or any safer than that.

This company has created a drug with the potential to slow, halt, and even reverse age-related diseases.

It's got the backing of the richest man in modern history: Jeff Bezos.

And it'll shake the foundation of the $18.3 trillion health-care industry to its core.

When it happens, anybody who got in early on this investment will be sitting on MOUNTAINS of cash.

I've made signing up today 100% risk-free for you. So, taking action won't put you at risk and will only give you the opportunity to grow your wealth substantially over the next few months.

My guarantee to you is that I will do my absolute best to find stocks on the verge of massive moves that you won't hear about from the mainstream media — or anywhere else, for that matter.

I appreciate you sticking around for this important presentation. I hope you take me up on this amazing offer today.

Just click the button below to get started.

This once-in-a-lifetime investment opportunity is yours for the taking. I urge you to take advantage of it today.

See you on the inside...

Sincerely,

Alex Koyfman Signature

Alex Koyfman
Founding Editor, New Century Report

subscribe-now-blue

Angel Publishing LLC, a general interest newsletter is not liable for the suitability or future investment performance of any securities or strategies discussed. Please note that we are not a registered investment firm or broker/dealer. Only a registered broker or investment advisor may advise you individually on the suitability and performance of your portfolio or specific investments.

Readers are advised that the material contained herein should be used solely for informational purposes. As a publisher of a financial newsletter of general and regular circulation, we cannot tender individual investment advice. We urge you to always conduct your own research and due diligence and obtain professional advice before making any investment decision.

We will not be liable for any loss or damage caused by a reader's reliance on information obtained on our web sites. Our readers are solely responsible for their own investment decisions. Historical investment return examples given are hypothetical, and not to be taken as representative of any individual's actual trading experience. Please click here to see our Details and Disclosures